Innovations with Ed Begley Jr. set to cover PathogenDx who provide technology for simple, effective, fast, and affordable DNA-based pathogen testing for cannabis, botanicals and food.
Company set to utilize a proprietary technique which involves the activation, purification, and extraction of cannabinoids using only ethanol and other food-grade components.
Strain protection and genetic identification are major issues for growers and breeders but a new technology may now allow them to identify and secure rights to their valuable intellectual property.
Tens of thousands of medical cannabis patients have tracked over 500,000 medical records on Strainprint's mobile patient journal, generating over 7 million data points on strain efficacy and patient use.
The panel discussion covered the barriers to understanding how cannabis can be used to alleviate chronic pain and potentially ease the opioid crisis.
With the launch of the BASInfused™ certified seal, cannabis consumers will be safe in the knowledge that the products they consume are safe and labeled correctly.
“We shared our pain-patch with leading pain doctors in the region and they were all excited”; Preliminary studies on pain-patch shows excellent results” said Bobban Subhadra, M.S., Ph.D, Chief Operating Officer of Apotheca.
Following the analysis of 40 consumer products, scientists are calling for standard hemp testing to include both CBD and THC.
Combining cannabinoids with radiotherapy and smart biomaterials could enhance therapeutic efficacy during the treatment of pancreatic and lung cancers.